FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder
byUniversity of California, Los AngelesUCLA's Dr. Donald Kohn with Marley Gaskins and her mother, Tamara Hogue. Marley was the first patient to enroll in the LAD-l clinical trial in 2019. Credit:
Updated on: April 29,2026
FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder
byUniversity of California, Los AngelesUCLA's Dr. Donald Kohn with Marley Gaskins and her mother, Tamara Hogue. Marley was the first patient to enroll in the LAD-l clinical trial in 2019. Credit:
Updated on:April 29,2026
